Related Experiment Video
Updated: Jul 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
British Society for Sexual Medicine guidelines on the management of erectile dysfunction
Geoff Hackett1, Phil Kell, David Ralph
1Holly Cottage Clinic, Fisherwick, Lichfield, UK. geoff.hackett@virgin.net
Insights
This study developed evidence-based guidelines for UK healthcare professionals on managing erectile dysfunction (ED). The new guidelines ensure clinical relevance and adherence to the UK healthcare system requirements.
Area of Science:
- Urology
- Sexual Medicine
- Evidence-Based Medicine
Background:
- Current UK erectile dysfunction (ED) management influenced by non-evidence-based guidance.
- Need for clinically relevant guidelines for primary and secondary care professionals.
Framework:
- Multidisciplinary panel of seven UK experts convened.
- Systematic review of peer-reviewed articles and randomized controlled trials.
- Evidence graded according to level of evidence.
Implementation:
- Panel meetings held between September 2006 and April 2007.
- Expert consensus and feedback facilitated by the chairman.
- Final guideline approved by panel members.
Implications:
- Provides comprehensive, evidence-based guidance for UK healthcare professionals.
- Facilitates adherence to unique UK healthcare system requirements.
- Available for download from BSSM and eguidelines websites.
Introduction:
UK primary care physicians are required to follow authoritative endorsed guidelines as part of their terms of service. The major influence on the management of erectile dysfunction in primary and secondary care between 1999 and 2007 has been Department of Health "guidance on good practice," a non-evidence-based document, essentially defining patients who qualify for government-funded treatment.
Aim:
To provide clinically based guidelines relevant to UK primary and secondary healthcare professionals in their daily practice.
Methods:
A multidisciplinary panel of seven UK experts including two primary care physicians from the British Society for Sexual Medicine met for two full day meetings between September 2006 and April 2007, with each member allocated to disease areas related to their specialty. Feedback and approval of all sections between panel members was facilitated by the chairman. Source information was obtained from peer reviewed articles, meetings and presentations. Articles were chosen from electronically searching the Cochrane Library, Medline and Embase for randomized controlled clinical trials and graded according to level of evidence.
Results:
Patient-reported sexual activity, satisfaction with sexual activity (Male Sexual Health Questionnaire), and treatment expectations; urologists' subjective assessment of the importance given by their patients to ED; the timing they propose for starting ED treatment.
Results:
After the second full day meeting in January 2007, the final version was approved by panel members and made available for healthcare professions by download from http://www.bssm.org and from http://www.eguidelines.co.uk
Conclusions:
A comprehensive evidence-based guideline has been developed that is highly relevant for primary and secondary care professionals enabling them to work within the unique requirements of the UK healthcare system.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Atherosclerosis III: Management
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Endocarditis III: Medical Management